Tazopen Injection (2 gm + 0.25 gm)/vial is a combination of Piperacillin, a broad-spectrum penicillin antibiotic, and Tazobactam, a β-lactamase inhibitor. This formulation is designed to treat moderate to severe bacterial infections, including those caused by β-lactamase-producing or penicillin-resistant bacteria. It provides comprehensive coverage against Gram-positive, Gram-negative, and anaerobic pathogens, making it highly effective in hospital and clinical settings.
রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন
Moderate to Severe Infections: Effective against respiratory, urinary tract, abdominal, skin, and soft tissue infections.
Hospital-Acquired Infections: Active against resistant bacterial strains commonly encountered in inpatient care.
Broad-Spectrum Coverage: Piperacillin targets bacteria, while Tazobactam inhibits β-lactamase enzymes that can destroy the antibiotic.
Enhanced Efficacy: Combination therapy increases antibacterial activity compared to Piperacillin alone.
Intravenous Administration: Provides rapid therapeutic action for acute infections.
Piperacillin: Inhibits bacterial cell wall synthesis, leading to cell lysis and bacterial death.
Tazobactam: Protects Piperacillin from degradation by β-lactamase enzymes.
Combined Effect: Ensures a wider spectrum of activity and effectiveness against resistant organisms.
Route: Intravenous infusion only.
Dosage Form: 2 gm Piperacillin + 0.25 gm Tazobactam per vial.
Administration: Dilute appropriately and infuse over 30 minutes to 1 hour.
Frequency: Typically every 6–8 hours depending on infection severity, renal function, and physician recommendation.
Monitoring: Kidney function, liver function, and blood counts should be regularly checked during therapy.
Medical History: Inform your healthcare provider if you have kidney or liver disease, gastrointestinal issues, or known penicillin allergy.
Pregnancy and Lactation: Use only if prescribed by a physician; benefits should outweigh risks.
Drug Interactions: May interact with anticoagulants, methotrexate, or other antibiotics; disclose all medications to your doctor.
Administration Considerations: Proper dilution and infusion rates reduce the risk of vein irritation or local reactions.
Tazopen Injection (2 gm + 0.25 gm)/vial is generally well tolerated. Potential side effects include:
Gastrointestinal: Nausea, vomiting, diarrhea, abdominal discomfort
Hypersensitivity Reactions: Rash, fever, itching, or rare anaphylaxis
Hematologic: Temporary changes in blood counts (neutropenia, thrombocytopenia)
Local Reactions: Pain or inflammation at the infusion site
Rare: Liver enzyme elevation or severe allergic reactions
Most side effects are manageable with monitoring and supportive care.
Store vials at 20–25°C (room temperature) in a dry place.
Protect from light and moisture.
Keep out of reach of children.
Tazopen Injection (2 gm + 0.25 gm)/vial is an effective and reliable option for treating moderate to severe bacterial infections. When administered under proper medical supervision, it ensures broad-spectrum antibacterial coverage and rapid infection control.
Login Or Registerto submit your questions to seller
No none asked to seller yet